Supplementary Data from BCA101 is a Tumor-Targeted Bifunctional Fusion Antibody that Simultaneously Inhibits EGFR and TGF-β Signalling to Durably Suppress Tumor Growth
Authors:
- Srinivas Reddy BoreddySBSrinivas Reddy Boreddy
- Reshmi NairRNReshmi Nair
- Prashant Kumar. PandeyPPPrashant Kumar. Pandey
- Anshu KuriakoseAKAnshu Kuriakose
- Shivakumar Bhadravathi. MarigowdaSMShivakumar Bhadravathi. Marigowda
- Chaitali DeyCDChaitali Dey
- Arindam BanerjeeABArindam Banerjee
- Hanumant KulkarniHKHanumant Kulkarni
- Milind SagarMSMilind Sagar
- Shiv Ram KrishnSKShiv Ram Krishn
- Shruthi RaoSRShruthi Rao
- Madhukara A RMRMadhukara A R
Open Access
- 16 September 2024
- other
- Published by American Association for Cancer Research (AACR)